Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-88

Folks, this is much more than Remestemcel-L for COVID-19 induced ARDS.
As I stated in my "Silviu Itescu and the Vatican" post yesterday, this EAP is strengthening the evidence that "inflammation is the link to all diseases".

Quotes from my (yesterday's) post:
"What is remarkable is the choice of Remestemcel-L in the EAP apparently to target multiple organs with MIS-C (hence the name "multisystem"), not just the lungs/lung tissue.Note that MIS-C affects heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.So this latest EAP for MIS-C could well prove to treat all these organs, not just the lungs/lung tissue (as is the case for COVID-19 induced ARDS).Is Remestemcel-L going to repair these other organs? That is the BILLION dollar question"

Also note, today's PR mentions approximately 50% of these cases involve the heart. So the other 50% involve lungs, kidneys, brain, skin, eyes, or gastrointestinal organs, since MIS-C involves inflammation of these critical organs as well.
Keep in mind this important statement in today's PR:
".... massive simultaneous inflammation of multiple critical organs and their vasculature."

Keyword: Inflammation.
Remestemcel-L will do many good things....it ain't just for the lungs anymore.